Obesity is a disease, not a lifestyle choice. At Ghalwash Hospital, we believe every patient deserves an informed understanding of their surgical options. This guide, drawn from decades of clinical experience, explains the different types of bariatric surgery, their benefits and risks, and how to make the right decision for your health.
السمنة مرض وليست عرض. المريض لازم يفهم كل التفاصيل قبل ما ياخد القرار — ده حقه وده واجبنا.
Bariatric surgery is not the first resort — it is a powerful tool for patients whose obesity causes or worsens serious medical conditions. The decision to pursue surgery depends on multiple factors:
Body Mass Index (BMI): Traditionally, patients with a BMI above 40 (or above 35 with comorbidities) are candidates. However, modern approaches consider the full clinical picture — a patient with a BMI of 30 who has developed diabetes and hypertension may benefit more than a patient with a BMI of 40 who has no comorbidities.
Comorbidities: Diabetes, hypertension, cardiovascular disease, joint deterioration, sleep apnea, and certain cancers are all linked to obesity.
Previous attempts: Patients who have tried diet, exercise, and lifestyle changes without sustained success are often candidates.
New medications: In the past five years, breakthrough GLP-1 agonist medications have transformed the landscape. These can be used before surgery, instead of surgery for some patients, or alongside surgery for optimal long-term results.
Sleeve gastrectomy involves the permanent removal of approximately 90% of the stomach, creating a narrow tube-shaped stomach. It is the most commonly performed bariatric procedure worldwide.
How it works: The reduced stomach capacity limits food intake, leading to significant weight loss — typically 25 to 60 kg in the first six months.
Important considerations:
• Irreversible — Once the stomach is removed, it cannot be restored. If future treatments (gene therapy, advanced medications) become available, patients cannot benefit from having their full stomach.
• Reflux risk — More than 50% of patients may develop acid reflux (GERD), potentially requiring lifelong medication.
• Stomach re-expansion — After 3-5 years, the remaining stomach can stretch, allowing patients to eat larger portions again. This is the primary cause of weight regain.
• Weight regain — Long-term failure rates are higher compared to gastric bypass procedures.
Despite these considerations, sleeve gastrectomy remains a valid option for many patients. The key is understanding these realities before making a decision — not after.
Gastric bypass creates a small stomach pouch and reroutes a section of the small intestine. Unlike sleeve gastrectomy, no stomach tissue is permanently removed — making the procedure potentially reversible.
Standard Gastric Bypass: Creates a small pouch connected to the small intestine. Success rate of approximately 66% at five years. The pouch can expand over time, similar to sleeve gastrectomy.
The Modified Gastric Bypass (التحويل المعدل): Our innovation involves three key modifications:
1. Ultra-small pouch — Even if the pouch expands, it grows from 'very small' to 'small' rather than from 'small' to 'normal'
2. External reinforcement — A band placed around the pouch limits expansion beyond a certain point
3. Optimized intestinal measurements — Precise calibration of the intestinal bypass ensures adequate nutrition while maximizing weight loss
Result: 91% long-term success rate versus 66% for standard gastric bypass.
Diabetes resolution: Gastric bypass produces hormonal changes that directly address insulin resistance — meaning even if a patient regains some weight, their diabetes often remains resolved. This is a fundamental advantage over sleeve gastrectomy, where diabetes improvement is weight-dependent.
Bariatric surgery at Ghalwash Hospital: